139 related articles for article (PubMed ID: 9434615)
1. The bioavailability of ginkgolides in Ginkgo biloba extracts.
Li CL; Wong YY
Planta Med; 1997 Dec; 63(6):563-5. PubMed ID: 9434615
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
Biber A; Koch E
Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
[TBL] [Abstract][Full Text] [Related]
3. Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity.
Liu XW; Yang JL; Niu W; Jia WW; Olaleye OE; Wen Q; Duan XN; Huang YH; Wang FQ; Du FF; Zhong CC; Li YF; Xu F; Gao Q; Li L; Li C
Acta Pharmacol Sin; 2018 Dec; 39(12):1935-1946. PubMed ID: 30054600
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].
Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A
Therapie; 1995; 50(2):137-44. PubMed ID: 7631288
[TBL] [Abstract][Full Text] [Related]
5. [Biological standardization of Ginkgo extracts].
Steinke B; Müller B; Wagner H
Planta Med; 1993 Apr; 59(2):155-60. PubMed ID: 8488195
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
[TBL] [Abstract][Full Text] [Related]
7. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
Smith PF; Maclennan K; Darlington CL
J Ethnopharmacol; 1996 Mar; 50(3):131-9. PubMed ID: 8691847
[TBL] [Abstract][Full Text] [Related]
8. [Gingkolides and bilobalide: structure, pharmacology, and synthesis].
Sviridov AF
Bioorg Khim; 1991 Oct; 17(10):1301-12. PubMed ID: 1804115
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.
Chatterjee SS; Kondratskaya EL; Krishtal OA
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S68-77. PubMed ID: 13130392
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model.
Wang S; Ouyang B; Aa J; Geng J; Fei F; Wang P; Wang J; Peng Y; Geng T; Li Y; Huang W; Wang Z; Xiao W; Wang G
J Pharm Biomed Anal; 2016 Jul; 126():109-16. PubMed ID: 27182682
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba for dementia.
Med Lett Drugs Ther; 1998 Jun; 40(1029):63-4. PubMed ID: 9653424
[No Abstract] [Full Text] [Related]
12. Ginkgolides and platelet-activating factor binding sites.
Hosford DJ; Domingo MT; Chabrier PE; Braquet P
Methods Enzymol; 1990; 187():433-46. PubMed ID: 2172741
[No Abstract] [Full Text] [Related]
13. Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract.
Huang P; Zhang L; Chai C; Qian XC; Li W; Li JS; Di LQ; Cai BC
J Pharm Biomed Anal; 2014 Nov; 100():138-144. PubMed ID: 25165009
[TBL] [Abstract][Full Text] [Related]
14. Determination of ginkgolide A, B, and bilobalide in biloba L. extracts by microdialysis-HPLC.
Chiu HL; Lin HY; Yang TC
Anal Bioanal Chem; 2004 Jun; 379(3):445-8. PubMed ID: 15057504
[TBL] [Abstract][Full Text] [Related]
15. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
[No Abstract] [Full Text] [Related]
16. Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.
Kressmann S; Biber A; Wonnemann M; Schug B; Blume HH; Müller WE
J Pharm Pharmacol; 2002 Nov; 54(11):1507-14. PubMed ID: 12495553
[TBL] [Abstract][Full Text] [Related]
17. Isolation of ginkgolides A, B, C, J and bilobalide from G. biloba extracts.
Jaracz S; Malik S; Nakanishi K
Phytochemistry; 2004 Nov; 65(21):2897-902. PubMed ID: 15501258
[TBL] [Abstract][Full Text] [Related]
18. Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
Iwamoto K; Kawamoto H; Takeshita F; Matsumura S; Ayaki I; Moriyama T; Zaima N
J Oleo Sci; 2019 Sep; 68(9):923-930. PubMed ID: 31413248
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts.
Koch E
Phytomedicine; 2005 Jan; 12(1-2):10-6. PubMed ID: 15693702
[TBL] [Abstract][Full Text] [Related]
20. Studies on the callus cultures of Ginkgo biloba and its metabolites-ginkgolides.
Yu R; Zhao H; Zheng Y; Yao X; Zhang H
Chin J Biotechnol; 1999; 15(1):51-8. PubMed ID: 10668135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
